Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Book ReviewBOOK REVIEWS

Vascular Disruptive Agents for the Treatment of Cancer

Anticancer Research March 2011, 31 (3) 1087-1088;
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 31 no. 3 1087-1088

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Published online April 15, 2011.

Copyright & Usage 
Copyright© 2011 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

PreviousNext
Back to top

In this issue

Anticancer Research: 31 (3)
Anticancer Research
Vol. 31, Issue 3
March 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Vascular Disruptive Agents for the Treatment of Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Vascular Disruptive Agents for the Treatment of Cancer
Anticancer Research Mar 2011, 31 (3) 1087-1088;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Vascular Disruptive Agents for the Treatment of Cancer
Anticancer Research Mar 2011, 31 (3) 1087-1088;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Book Reviews
  • Book Reviews
  • Goodman’s Basic Medical Endocrinology. 5th Edition. Edited by E. Holt, B. Lupsa, G. Lee, H. Bassyouni, H. Peery. 2021, pp 552, USD 106.25, ISBN: 978-0-128-15844-9. Academic Press, Elsevier, Cambridge, MA, USA.
Show more Book Reviews

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire